Annexon
Annexon is an innovative neurodegeneration therapeutics by targeting complement company founded in 2011 by Ben Barres.
1
Funding Rounds
$102.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ar*** Ro******* |
|
- | |
| Be* Ba**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mu**** Sa**** | - | - | - |
| Th**** G. Wi***** | - | - | - |
| Do***** Lo** |
|
- | - |
| Wi***** H. Ca**** | - | - | linkedin twitter facebook |
Industries
Annexon is active in the following industries: